Events / Exhibitions

Exhibition Life Science Cell Culture Pharma Manufacturing & QC

ISSCR 2025: Hong Kong, 11th - 14th Jun, 2025

Date 11th - 14th Jun, 2025

Place Hong Kong, CHINAHong Kong Convention and Exhibition Centre

Date: 11th - 14th Jun, 2025
Place: Hong Kong Convention and Exhibition Centre
Address: 1 Expo DriveWan Chai, Hong Kong Island Hong Kong SAR CHINA
Booth#: 707
Who should attend: Cell biologists, Stem cell researchers, Gene and cell therapy community, Cell manufacturers, Bioengineers

Date & Time: 12:30-12:55 p.m., Jun 11th (Wed) 2025
Place: 3G, Level 3
Speaker: Dr. Masahiro Kino-oka, Professor, Department of Biotechnology, Graduate School of Engineering, Osaka University
Showcase Title: Breakthrough strategies using novel reagents in mass production with iPSC expansion & differentiation
Abstract: The optimized protocols for expansion and differentiation of iPS cells on a small laboratory scale are subject to extreme degradation against target cell yield and its stability between when scaled up to full-scale production. It is desirable to develop methodology for equivalent performance in mass production with scale-up. In particular, cell death in the early phase of iPS expansion (after cell seeding to initiation of cell division) and in the early induction phase of differentiation (first step of induction from undifferentiated state) are considered to impact the yield and its batch-to-batch variability of the target differentiated cells. Here, I will present breakthrough strategies using novel reagents that improve yield and stability in mass cell production.

Date & Time: 13:00-13:30 p.m., Jun 11th (Wed) 2025
Place: 3G, Level 3
Speaker: Dr. Kim Mee-Hae, Ph.D., Associate Professor, Department of Biotechnology, Graduate School of Engineering, Osaka University
Showcase Title: Technological strategy for realizing the production revolution of differentiated cells from iPSC using botulinum hemagglutinin
Abstract: Although the potential of iPSCs to differentiate into various cell types has shown great application promise in regenerative medicine, variation in differentiation efficiency and low reproducibility significantly limit their practical application. Here, I will introduce a novel culture strategy for generating synchronous iPSC-derived differentiated cells using botulinum hemagglutinin (HA). This approach is not only a simple and efficient way to increase iPSC homogeneity, but also a synchronous differentiation method to produce target cells during multistep differentiation. HA may play an important role as a tool for culture stabilization because it can improve the robustness of the differentiation process of various differentiated cell types such as hepatocytes, pancreatic progenitors, cardiomyocytes, neural progenitors, and retinal pigment epithelial cells.

Date & Time: 16:00 p.m. - 17:00 p.m., Jun 13th (Fri) 2025
Place: F1295
Presenter: Saki Kado, Technical Marketing Department, FUJIFILM Wako Pure Chemical Corporation
Poster Title: MSC-derived extracellular vesicles obtained using PS-affinity method showed higher anti-inflammatory activities than other conventional methods.